Xarelto Versus no Treatment for the Prevention of Recurrent Thrombosis in Patients With Chronic Portal Vein Thrombosis.
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 112 participants.
Also called NCT02555111
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 112 participants
- Registry
-
NCT02555111 -
2015-001190-40
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- France
- Registry status
- Completed
Technical summary
Registry record NCT02555111. Randomized; no masking; primary purpose treatment. Start 2015-09 (actual); primary completion 2020-02 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Xarelto Versus no Treatment for the Prevention of Recurrent Thrombosis in Patients With Chronic Portal Vein Thrombosis.
- Acronym
- RIPORT
- Condition
- Deep Vein Thrombosis
- Condition
- Chronic Portal Vein Thrombosis
- Intervention (Drug)
- Xarelto
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
Record details
- Record id
cardio:ct-nct02555111- Content hash
4a92e8a73c6eeecd18a356902af94ef94c0e409d1eab506adbd5d04224f1d510